COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value per share (COLL) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2015 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
COLL on Nasdaq
Shares outstanding
31,637,125
Price per share
$45.53
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
35,632,398
Total reported value
$1,649,358,186
% of total 13F portfolios
0%
Share change
-138,758
Value change
+$649,641
Number of holders
267
Price from insider filings
$45.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value per share (COLL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 16% $133,841,807 4,997,827 BlackRock, Inc. 31 Mar 2025
EVENTIDE ASSET MANAGEMENT, LLC 5.9% $85,425,162 1,876,239 Eventide Asset Management, LLC 31 Dec 2025
RENAISSANCE TECHNOLOGIES LLC 5.1% +4.8% $55,955,623 +$2,729,885 1,599,189 +5.1% Renaissance Technologies LLC 08 Sep 2025
Invesco Ltd. 4.9% -10% $48,100,835 -$5,793,481 1,584,871 -11% Invesco Ltd. 30 Jun 2025
Rubric Capital Management LP 4.7% -51% $68,132,731 -$68,457,269 1,496,436 -50% Rubric Capital Management LP 31 Dec 2025
PRINCIPAL GLOBAL INVESTORS 4.6% $44,508,457 1,466,506 PRINCIPAL GLOBAL INVESTORS 30 Jun 2025
Pacer Advisors, Inc. 1.1% -87% $11,222,855 -$46,153,054 419,076 -80% Pacer Advisors, Inc. 31 Mar 2025

As of 31 Dec 2025, 267 institutional investors reported holding 35,632,398 shares of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value per share (COLL). This represents 113% of the company’s total 31,637,125 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value per share (COLL) together control 87% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 5,099,702 -1.5% 0% $236,116,204
VANGUARD GROUP INC 7.1% 2,256,254 +1.3% 0% $104,464,562
EVENTIDE ASSET MANAGEMENT, LLC 5.9% 1,876,239 -22% 1.4% $86,882,042
RENAISSANCE TECHNOLOGIES LLC 5.1% 1,617,349 +1.1% 0.12% $74,883,259
FULLER & THALER ASSET MANAGEMENT, INC. 4.7% 1,500,072 -0.17% 0.23% $69,453,332
Rubric Capital Management LP 4.7% 1,496,436 -47% 0.83% $69,284,987
JANUS HENDERSON GROUP PLC 4.6% 1,448,578 +59% 0.03% $67,026,050
PRINCIPAL FINANCIAL GROUP INC 4.2% 1,313,662 +0.3% 0.03% $60,822,551
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 4.1% 1,312,655 +65% 0.02% $60,775,927
STATE STREET CORP 4.1% 1,310,641 +1.3% 0% $60,682,678
DIMENSIONAL FUND ADVISORS LP 2.6% 830,480 -0.07% 0.01% $38,453,747
GEODE CAPITAL MANAGEMENT, LLC 2.6% 829,453 -0.83% 0% $38,409,453
MORGAN STANLEY 2.2% 684,613 -11% 0% $31,697,660
D. E. Shaw & Co., Inc. 2.1% 653,874 +68% 0.02% $30,274,367
GOLDMAN SACHS GROUP INC 2% 647,537 -19% 0% $29,980,963
EMERALD ADVISERS, LLC 2% 629,344 -1.6% 0.9% $29,138,627
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.7% 543,773 +1513% 0.01% $25,176,690
Assenagon Asset Management S.A. 1.6% 511,698 +162% 0.04% $23,691,617
MARSHALL WACE, LLP 1.6% 492,360 +76% 0.02% $22,796,272
VICTORY CAPITAL MANAGEMENT INC 1.4% 457,295 -4.7% 0.01% $21,172,759
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% 447,282 +9.9% 0% $20,709,157
EMERALD MUTUAL FUND ADVISERS TRUST 1.2% 391,670 -1% 0.88% $18,134,321
TWO SIGMA INVESTMENTS, LP 1.2% 366,099 +36% 0.03% $16,950,384
NORTHERN TRUST CORP 1.1% 353,604 -4.8% 0% $16,371,866
LSV ASSET MANAGEMENT 1.1% 347,900 +0.38% 0.04% $16,108,000

Institutional Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value per share (COLL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 35,632,398 $1,649,358,186 +$649,641 $46.30 267
2025 Q3 36,987,734 $1,294,013,273 +$43,990,267 $34.99 241
2025 Q2 35,739,346 $1,056,745,851 -$27,671,390 $29.57 221
2025 Q1 36,773,847 $1,097,284,609 -$11,471,996 $29.85 241
2024 Q4 37,138,457 $1,064,290,472 -$54,467,577 $28.65 238
2024 Q3 38,489,790 $1,486,827,407 -$25,778,054 $38.64 248
2024 Q2 39,660,571 $1,277,281,895 -$10,053,520 $32.20 229
2024 Q1 39,565,870 $1,535,798,999 +$15,800,408 $38.82 226
2023 Q4 39,202,475 $1,206,720,767 +$15,870,252 $30.78 190
2023 Q3 38,712,156 $865,246,259 -$10,117,275 $22.35 174
2023 Q2 39,246,501 $843,481,973 +$2,463,793 $21.49 177
2023 Q1 39,049,844 $936,805,999 +$74,091,480 $23.99 196
2022 Q4 36,094,328 $837,390,551 +$6,535,089 $23.20 174
2022 Q3 35,876,068 $574,780,379 -$19,538,698 $16.02 158
2022 Q2 36,430,591 $645,532,750 +$14,193,849 $17.72 152
2022 Q1 36,080,262 $733,927,682 +$6,776,837 $20.36 161
2021 Q4 35,805,022 $668,826,744 -$13,881,763 $18.68 152
2021 Q3 36,444,427 $719,484,752 -$39,361,775 $19.74 150
2021 Q2 37,987,862 $898,085,585 -$27,328 $23.64 155
2021 Q1 38,008,378 $900,688,845 +$32,135,922 $23.70 161
2020 Q4 37,131,836 $744,007,768 -$8,934,464 $20.03 135
2020 Q3 39,011,062 $812,260,717 +$4,160,811 $20.82 140
2020 Q2 37,020,602 $647,728,854 +$3,968,987 $17.50 149
2020 Q1 36,901,564 $602,550,993 +$85,027,216 $16.33 157
2019 Q4 31,512,474 $648,599,114 +$50,675,226 $20.58 134
2019 Q3 30,030,196 $344,731,286 -$4,710,643 $11.48 116
2019 Q2 30,820,855 $405,253,075 -$9,461,407 $13.15 127
2019 Q1 31,440,940 $476,061,688 -$37,383,003 $15.14 142
2018 Q4 33,763,313 $579,232,154 +$15,811,423 $17.17 119
2018 Q3 33,465,415 $491,620,289 +$14,683,142 $14.74 122
2018 Q2 31,032,309 $740,054,845 +$15,772,890 $23.85 131
2018 Q1 30,253,700 $772,956,896 +$49,280,895 $25.55 135
2017 Q4 28,485,885 $526,126,077 +$70,690,864 $18.46 99
2017 Q3 26,039,739 $273,144,788 +$14,140,125 $10.49 74
2017 Q2 24,547,432 $307,092,409 +$19,595,869 $12.51 69
2017 Q1 23,352,469 $234,899,241 +$9,397,867 $10.06 80
2016 Q4 23,305,863 $362,917,530 +$115,650,426 $15.57 86
2016 Q3 15,869,884 $305,753,967 +$28,932,707 $19.26 71
2016 Q2 14,623,227 $173,348,652 -$11,495,754 $11.85 73
2016 Q1 14,863,823 $269,759,000 +$54,374,659 $18.15 70
2015 Q4 11,882,728 $326,630,223 -$5,739,748 $27.50 58
2015 Q3 10,244,867 $226,510,468 +$24,645,746 $22.11 45
2015 Q2 9,280,769 $165,466,756 +$165,466,759 $17.84 45